Hepatocellular carcinoma locoregional therapies for patients in the waiting list. Impact on transplantability and recurrence rate

Journal of Hepatology

Volumn 58, Issue 3, 2013, Pages 609-618

  Cescon, Matteo ^a   Cucchetti, Alessandro ^a   Ravaioli, Matteo ^a   Pinna, Antonio Daniele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Locoregional treatments

Indexed keywords

ALPHA FETOPROTEIN; EPITHELIAL CELL ADHESION MOLECULE;

ABLATION THERAPY; ADJUVANT THERAPY; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CHEMOEMBOLIZATION; COMPUTER ASSISTED RADIOTHERAPY; CRYOABLATION; GRAFT SURVIVAL; GROWTH; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER NECROSIS; LIVER TRANSPLANTATION; MICROWAVE THERAPY; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOFREQUENCY ABLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENCE FREE SURVIVAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT RESPONSE; TUMOR DIFFERENTIATION;

EID: 84874116481     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.09.021     Document Type: Note

References (77)

1. H.B. El-Serag, J.A. Davila, N.J. Petersen, and K.A. McGlynn The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 139 2003 817 823
2. IARC. Available from http://www-dep.iarc.fr/; 2011 (accessed 20.06.12).
3. G. Millonig, I.W. Graziadei, M.C. Freund, W. Jaschke, S. Stadlmann, and R. Ladurner Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma Liver Transpl 13 2007 272 279
4. V. Mazzaferro, C. Battiston, S. Perrone, A. Pulvirenti, E. Regalia, and R. Romito Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study Ann Surg 240 2004 900 909
5. R. Lencioni, D. Cioni, L. Crocetti, C. Franchini, C.D. Pina, and J. Lera Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation Radiology 234 2005 961 967
6. M. Del Gaudio, G. Ercolani, M. Ravaioli, M. Cescon, A. Lauro, and M. Vivarelli Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience Am J Transplant 8 2008 1177 1185
7. R. Golfieri, A. Cappelli, A. Cucchetti, F. Piscaglia, M. Carpenzano, and E. Peri Efficacy of selective transarterial chemoembolization in inducing tumor necrosis in small (<5 cm) hepatocellular carcinomas Hepatology 53 2011 1580 1589
8. V. Mazzaferro, E. Regalia, R. Doci, S. Andreola, A. Pulvirenti, and F. Bozzetti Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
9. F.Y. Yao, L. Ferrell, N.M. Bass, J.J. Watson, P. Bacchetti, and A. Venook Liver transplantation for hepatocellular carcinoma: expansion of the tumour size limits does not adversely impact survival Hepatology 33 2001 1394 1403
10. P.A. Clavien, M. Lesurtel, P.M.M. Bossuyt, G.J. Gores, B. Langer, and A. Perrier Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report Lancet Oncol 13 2012 e11 e22
11. J.M. Llovet, X. Mas, J.J. Aponte, J. Fuster, M. Navasa, and E. Christensen Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation Gut 50 2002 123 128
12. P. Majno, E. Giostra, and G. Mentha Management of hepatocellular carcinoma on the waiting list before liver transplantation: time for controlled trials? Liver Transpl 13 2007 S27 S35
13. P.E. Majno, R. Lencioni, F. Mornex, N. Girard, R.T. Poon, and D. Cherqui Is treatment of HCC on the waiting list necessary? Liver Transpl 17 2011 S98 S108
14. T.A. Aloia, R. Adam, D. Samuel, D. Azoulay, and D. Castaing A decision analysis model identifies the interval of efficacy for transarterial chemoembolization [TACE] in cirrhotic patients with hepatocellular carcinoma awaiting liver transplantation J Gastrointest Surg 11 2007 1328 1332
15. R. Lencioni, and J.M. Llovet Modified RECIST (mRECIST) assessment for hepatocellular carcinoma Sem Liv Dis 30 2010 52 60
16. J.M. Llovet, A.M. Di Bisceglie, J. Bruix, B.S. Kramer, R. Lencioni, and A.X. Zhu Panel of experts in HCC-design clinical trials. Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 2008 698 711
17. J. Bruix, and M. Sherman Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
18. J.M. Llovet, M. Ducreux, R. Lencioni, A.M. Di Bisceglie, P.R. Galle, and J.F. Dufour EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma J Hepatol 56 2012 908 943
19. J.M. Llovet, and J. Bruix Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 2003 429 442
20. J. Lammer, K. Malagari, T. Vogl, F. Pilleul, A. Denys, and A. Watkinson Prospective randomised study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study Cardiovasc Intervent Radiol 33 2010 41 52
21. M. Varela, M.I. Real, M. Burrel, A. Forner, M. Sala, and M. Brunet Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics J Hepatol 46 2007 474 481
22. 131I-labeled-iodized oil in the treatment of hepatocellular carcinoma Hepatology 26 1997 1156 1161
23. R. Salem, R.J. Lewandowski, M.F. Mulcahy, A. Riaz, R.K. Ryu, and S. Ibrahim Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes Gastroenterology 138 2010 52 64
24. 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis Hepatology 47 2008 71 81
25. P. Hilgard, M. Hamami, A.E. Fouly, A. Scherag, S. Müller, and J. Ertle Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival Hepatology 52 2010 1741 1749
26. E. Ben-Josef, D. Normolle, W.D. Ensminger, S. Walker, D. Tatro, and R.K. Ten Haken Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies J Clin Oncol 23 2005 8739 8747
27. P.E. Majno, R. Adam, H. Bismuth, D. Castaing, A. Ariche, and J. Krissat Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis Ann Surg 226 1997 688 701
28. J.I. Herrero, B. Sangro, J. Quiroga, F. Pardo, M. Herraiz, and J.A. Cienfuegos Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma Liver Transpl 7 2001 631 636
29. I.W. Graziadei, H. Sandmueller, P. Waldenberger, A. Koenigsrainer, K. Nachbaur, and W. Jaschke Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome Liver Transpl 9 2003 557 563
30. F.Y. Yao, N.M. Bass, B. Nikolai, R. Merriman, T.J. Davern, and R. Kerlan A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implications for the current organ allocation policy Liver Transpl 9 2003 684 692
31. P.H. Hayashi, M. Ludkowski, L.M. Forman, M. Osgood, S. Johnson, and M. Kugelmas Hepatic artery chemoembolization for hepatocellular carcinoma in patients listed for liver transplantation Am J Transplant 4 2004 782 787
32. R.A. Fisher, D. Maluf, A.H. Cotterell, T. Stravitz, L. Wolfe, and V. Luketic Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list Clin Transplant 18 2004 502 512
33. Y.K. Maddala, L. Stadheim, J.C. Andrews, L.J. Burgart, C.B. Rosen, and W.K. Kremers Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization Liver Transpl 10 2004 449 455
34. G. Otto, S. Herber, M. Heise, A.W. Lohse, C. Mönch, and F. Bittinger Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma Liver Transpl 12 2006 1260 1267
35. P.M. Porrett, H. Paterman, M. Rosen, S. Sonnad, M. Soulen, and J.F. Markmann Lack of benefit of pretransplant locoregional hepatic therapy for hepatocellular carcinoma in the current MELD era Liver Transpl 12 2006 665 673
36. T.I. Huo, Y.H. Huang, C.W. Su, H.C. Lin, J.H. Chiang, and Y.Y. Chiou Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy Clin Transplant 22 2008 469 475
37. W. De Luna, D.Y. Sze, A. Ahmed, B.Y. Ha, W. Ayoub, and E.B. Keeffe Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation Am J Transplant 9 2009 1158 1168
38. E. Vibert, D. Azoulay, E. Hoti, S. Iacopinelli, D. Samuel, and C. Salloum Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor Am J Transplant 10 2010 129 137
39. M. De Giorgio, S. Vezzoli, E. Cohen, E. Armellini, M.G. Lucà, and G. Verga Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria Liver Transpl 16 2010 503 512
40. A. Vitale, F. D'Amico, A.C. Frigo, F. Grigoletto, A. Brolese, and G. Zanus Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation Ann Surg Oncol 17 2010 2290 2302
41. A. Cucchetti, M. Cescon, E. Bigonzi, F. Piscaglia, R. Golfieri, and G. Ercolani Priority of candidates with hepatocellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy Liver Transpl 17 2011 1344 1354
42. O. Ciccarelli, Q. Lai, P. Goffette, P. Finet, C. De Reyck, and F. Roggen Liver transplantation for hepatocellular cancer: UCL experience in 137 adult cirrhotic patients. Alpha-foetoprotein level and locoregional treatment as refined selection criteria Transpl Int 25 2012 867 875
43. S. Roayaie, J.S. Frischer, S.H. Emre, T.M. Fishbein, P.A. Sheiner, and M. Sung Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters Ann Surg 235 2002 533 539
44. W.C. Chapman, M.B. Majella Doyle, J.E. Stuart, N. Vachharajani, J.S. Crippin, and C.D. Anderson Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation Ann Surg 248 2008 617 625
45. F.Y. Yao, R.K. Kerlan Jr, R. Hirose, T.J. Davern 3rd, N.M. Bass, and S. Feng Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis Hepatology 48 2008 819 827
46. M. Ravaioli, G.L. Grazi, F. Piscaglia, F. Trevisani, M. Cescon, and G. Ercolani Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria Am J Transplant 8 2008 2547 2557
47. R.J. Lewandowski, L.M. Kulik, A. Riaz, S. Senthilnathan, M.F. Mulcahy, and R.K. Ryu A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization Am J Transplant 9 2009 1920 1928
48. J.W. Jang, C.R. You, C.W. Kim, S.H. Bae, S.K. Yoon, and Y.K. Yoo Benefit of downstaging hepatocellular carcinoma in a liver transplant population Aliment Pharmacol Ther 31 2010 415 423
49. D.S. Lu, N.C. Yu, S.S. Raman, P. Limanond, C. Lassman, and K. Murray Radiofrequancy ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver Radiology 234 2005 954 960
50. M. Pompili, V.G. Mirante, G. Rondinara, L.R. Fassati, F. Piscaglia, and S. Agnes Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and safety for tumor recurrence Liver Transpl 11 2005 1117 1126
51. T. Decaens, F. Roudot-Thoraval, S. Bresson-Hadni, C. Meyer, J. Gugenheim, and F. Durand Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma Liver Transpl 11 2005 767 775
52. J.M. Llovet, J. Fuster, and J. Bruix Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology 30 1999 1434 1440
53. K. Washburn, E. Edwards, A. Harper, and R. Freeman Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system Am J Transplant 10 2010 1643 1648
54. S.J. Pelletier, S. Fu, V. Thyagarajan, C. Romero-Marrero, M.J. Batheja, and J.D. Punch An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data Liver Transpl 15 2009 859 868
55. M. Lesurtel, B. Müllhaupt, B.C. Pestalozzi, T. Pfammatter, and P.A. Clavien Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis Am J Transplant 6 2006 2644 2650
56. R.B. Freeman Jr., D.E. Steffick, M.K. Guidinger, D.G. Farmer, C.L. Berg, and R.M. Merion Liver and intestine transplantation in the United States, 1997-2006 Am J Transplant 8 2008 958 976
57. M. Schwartz, S. Roayaie, and P. Uva Treatment of HCC in patients awaiting liver transplantation Am J Transplant 7 2007 1875 1881
58. M. Fujiki, F. Aucejo, and R. Kim General overview of neo-adjuvant therapy fro hepatocellular carcinoma before liver transplantation: necessity of option? Liver Int 31 2011 1081 1089
59. C. Toso, G. Mentha, N.M. Kneteman, and P. Majno The place of downstaging for hepatocellular carcinoma J Hepatol 52 2010 930 936
60. R.B. Freeman, A. Mithoefer, R. Ruthazer, K. Nguyen, A. Schore, and A. Harper Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN database Liver Transpl 12 2006 1504 1511
61. UNOS/OPTN. Modifications to policy 3.6.4.4 (Liver candidates with hepatocellular carcinoma). 3.6. Allocation of Livers. Last access on 01 July 2009. Available from http://www.unos.org/PoliciesandBylaws2/policies/docs/ policy8.doc.
62. R.B. Freeman, E.B. Edwards, and A.M. Harper Waiting list removal rates among patients with chronic and malignant liver diseases Am J Transplant 6 2006 1416 1421
63. E.A. Pomfret, K. Washburn, C. Wald, M.A. Nalesnik, D. Douglas, and M. Russo Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States Liver Transpl 16 2010 262 278
64. A. Cucchetti, M. Cescon, V. Bertuzzo, E. Bigonzi, G. Ercolani, and M.C. Morelli Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? Am J Transplant 11 2011 1696 1704
65. J.P. Roberts, A. Venook, R. Kerlan, and F. Yao Hepatocellular carcinoma: ablate and wait versus rapid transplantation Liver Transpl 16 2010 925 929
66. C. Toso, E. Dupuis-Lozeron, P. Majno, T. Berney, N.M. Kneteman, and T. Perneger A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list Hepatology 56 2012 149 156
67. C. Toso, S. Asthana, D.L. Bigam, A.M. Shapiro, and N.M. Kneteman Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database Hepatology 49 2009 832 838
68. K. Hasegawa, H. Imamura, M. Ijichi, Y. Matsuyama, K. Sano, and Y. Sugawara Inclusion of tumor markers improves the correlation of the Milan criteria with vascular invasion and tumor cell differentiation in patients with hepatocellular carcinoma undergoing liver resection (#JGSU-D-07-00462) J Gastrointest Surg 12 2008 858 866
69. H.S. Kim, J.W. Park, J.S. Jang, H.J. Kim, W.G. Shin, and K.H. Kim Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study J Clin Gastroenterol 43 2009 482 488
70. J.M. Llovet, V. Paradis, M. Kudo, and J. Zucman-Rossi Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma Liver Transpl 17 2011 S67 S71
71. T. Yamashita, M. Forgues, W. Wang, J.W. Kim, Q. Ye, and H. Jia EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma Cancer Res 68 2008 1451 1461
72. T. Yamashita, J. Ji, A. Budhu, M. Forgues, W. Yang, and H.Y. Wang EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features Gastroenterology 136 2009 1012 1024
73. S. Boyault, D.S. Rickman, A. De Reyniès, C. Balabaud, S. Rebouissou, and E. Jeannot Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets Hepatology 45 2007 42 52
74. J. Ji, J. Shi, A. Budhu, Z. Yu, M. Forgues, and S. Roessler MicroRNA expression, survival, and response to interferon in liver cancer N Engl J Med 361 2009 1437 1447
75. Y. Hoshida, A. Villanueva, M. Kobayashi, J. Peix, D.Y. Chiang, and A. Camargo Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med 359 2008 1995 2004
76. A. Budhu, M. Forgues, Q.H. Ye, H.L. Jia, P. He, and K.A. Zanetti Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment Cancer Cell 10 2006 99 111
77. M. Schwartz, I. Dvorchik, S. Roayaie, M.I. Fiel, S. Finkelstein, and J.W. Marsh Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers J Hepatol 49 2008 581 588